1887

Journal of Medical Microbiology logo

Volume 70, Issue 7

Serum biomarkers to differentiate Gram-negative, Gram-positive and fungal infection in febrile patients No Access

Abstract

Contamination of specimens and overuse of broad spectrum antibiotics contribute to false positives and false negatives, respectively. Therefore, useful and applicable biomarkers of bacteremia are still required.

IL-6 can be used as a serum biomarker to discriminate among bacterial infections and fungal infections in febrile patients with a bloodstream infection.

We aimed to evaluate the diagnostic efficiency of neutrophil/lymphocyte ratio (NLR), procalcitonin (PCT) and interleukin-6 (IL-6) in discriminating Gram-negative (G) bacteria from Gram-positive (G) bacteria and fungi in febrile patients.

A total of 567 patients with fever were evaluated. Serum levels of IL-6, PCT, NLR and CRP were compared among a G group (=188), a G group (=168), a fungal group (=38) and a culture negative group (=173). Sensitivity, specificity, Yuden’s index and area under the Receiver operating characteristic (ROC) curve (AUC) were obtained to analyse the diagnostic abilities of these biomarkers in discriminating bloodstream infection caused by different pathogens.

Serum IL-6 and PCT in the G group increased significantly when compared with both the G group and fungal group ( <0.05). AUC of IL-6 (0.767, 95 % CI:0.725–0.805) is higher than AUC of PCT (0.751, 95 % CI:0.708–0.796) in discriminating the G group from G group. When discriminating the G group from fungal group, the AUC of IL-6 (0.695, 95 % CI:0.651–0.747) with a cut-off value of 464.3 pg ml was also higher than the AUC of PCT (0.630, 95 % CI:0.585–0.688) with a cut-off value of 0.68 ng ml. Additionally, AUC of NLR (0.685, 95 % CI:0.646–0.727) in discriminating the fungal group from G group at the cut-off value of 9.03, was higher than AUC of IL-6, PCT and CRP.

This study suggests that IL-6 could be used as a serum biomarker to discriminate among bacterial infections and fungal infections in febrile patients with a bloodstream infection. In addition, NLR is valuable to discriminate fungal infections from Gram-positive infections in febrile patients with a bloodstream infection.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): bloodstream infection , febrile , Interleukin-6 and neutrophil/lymphocyte ratio (NLR)
© 2021 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001360
2021-07-14
2024-04-24
Loading full text...

Full text loading...

References

  1. Thriemer K, Ley B, Ame SS, Deen JL, Pak GD et al. Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the WHO case definitions. PLoS One 2012; 7:e51823 [View Article] [PubMed]
     [Google Scholar]
  2. Sharma NP, Peacock SJ, Phumratanaprapin W, Day N, White N et al. A hospital-based study of bloodstream infections in febrile patients in Dhulikhel Hospital Kathmandu University Teaching Hospital. Southeast Asian J Trop Med Public Health 2006; 37:351–356 [PubMed]
     [Google Scholar]
  3. Viswanathan VK. Off-label abuse of antibiotics by bacteria. Gut Microbes 2014; 5:3–4 [View Article] [PubMed]
     [Google Scholar]
  4. Tian L, Sun Z, Zhang Z. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. BMC Public Health 2018; 18:1121 [View Article] [PubMed]
     [Google Scholar]
  5. Arega B, Woldeamanuel Y, Adane K, Sherif AA, Asrat D. Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia. Infect Drug Resist 2018; 11:1511–1519 [View Article] [PubMed]
     [Google Scholar]
  6. Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R et al. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev 2010; 23:235–251 [View Article] [PubMed]
     [Google Scholar]
  7. Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Bürgi U et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis 2010; 29:269–277 [View Article] [PubMed]
     [Google Scholar]
  8. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39:206–217 [View Article] [PubMed]
     [Google Scholar]
  9. Lubell Y, Blacksell SD, Dunachie S, Tanganuchitcharnchai A, Althaus T et al. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia. BMC Infect Dis 2015; 15:511 [View Article] [PubMed]
     [Google Scholar]
  10. Minnaard MC, van de Pol AC, Broekhuizen BD, Verheij TJ, Hopstaken RM et al. Analytical performance, agreement and user-friendliness of five C-reactive protein point-of-care tests. Scand J Clin Lab Invest 2013; 73:627–634 [View Article] [PubMed]
     [Google Scholar]
  11. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005; 117:104–111 [View Article] [PubMed]
     [Google Scholar]
  12. Meisner M. Biomarkers of SEPSIS: Clinically useful?. Curr Opin Crit Care 2005473–480
     [Google Scholar]
  13. Yan ST, Sun LC, Jia HB, Gao W, Yang JP et al. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med 2017; 35:579–583 [View Article] [PubMed]
     [Google Scholar]
  14. Plesko M, Suvada J, Makohusova M, Waczulikova I, Behulova D et al. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients. Neoplasma 2016; 63:752–760 [View Article] [PubMed]
     [Google Scholar]
  15. Urbonas V, Eidukaite A, Tamuliene I. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer. J Pediatr Hematol Oncol 2012; 34:122–127 [View Article] [PubMed]
     [Google Scholar]
  16. Kumar S, Ingle H, Prasad DV, Kumar H. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol 2013; 39:229–246 [View Article] [PubMed]
     [Google Scholar]
  17. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007; 109:1574–1583 [View Article] [PubMed]
     [Google Scholar]
  18. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008; 34:55–60 [View Article] [PubMed]
     [Google Scholar]
  19. Halazun KJ, Hardy MA, Rana AA, Woodland DC, Luyten EJ et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009; 250:141–151 [View Article] [PubMed]
     [Google Scholar]
  20. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137:425–428 [View Article] [PubMed]
     [Google Scholar]
  21. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91:181–184 [View Article] [PubMed]
     [Google Scholar]
  22. Goodman DA, Goodman CB, Monk JS. Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg 1995; 61:257–259 [PubMed]
     [Google Scholar]
  23. de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010; 14:R192 [View Article] [PubMed]
     [Google Scholar]
  24. Vilahur G, Badimon L. Biological actions of pentraxins. Vascul Pharmacol 2015; 73:38–44 [View Article] [PubMed]
     [Google Scholar]
  25. Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful?. Crit Care Clin 2006; 22:503–519 [View Article] [PubMed]
     [Google Scholar]
  26. Li S, Rong H, Guo Q, Chen Y, Zhang G et al. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci 2016; 21:39 [View Article] [PubMed]
     [Google Scholar]
  27. Qu J, Lu X, Liu Y, Wang X. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients. Indian J Med Res 2015; 141:315–321
     [Google Scholar]
  28. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012; 25:609–634 [View Article] [PubMed]
     [Google Scholar]
  29. Guo SY, Zhou Y, Hu QF, Yao J, Wang H. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci 2015; 349:499–504
     [Google Scholar]
  30. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23:539–544 [View Article] [PubMed]
     [Google Scholar]
  31. Demirdal T, Sen P, Nemli SA. Diagnostic value of procalcitonin in predicting bacteremia in intensive care unit. Indian J Crit Care Med 2018; 22:78–84 [View Article] [PubMed]
     [Google Scholar]
  32. Christ-Crain M, Müller B. Procalcitonin in bacterial infections--hype, hope, more or less?. Swiss Med Wkly 2005; 135:451–460 [PubMed]
     [Google Scholar]
  33. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13:426–435 [View Article] [PubMed]
     [Google Scholar]
  34. Nakajima A, Yazawa J, Sugiki D, Mizuguchi M, Sagara H et al. Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens. Intern Med 2014; 53:1497–1503 [View Article] [PubMed]
     [Google Scholar]
  35. Markova M, Brodska H, Malickova K, Válková V, Cetkovský P et al. Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients. Support Care Cancer 2013; 21:2733–2742 [View Article] [PubMed]
     [Google Scholar]
  36. Brodska H, Malickova K, Adamkova V, Benáková H, Šťastná MM et al. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med 2013; 13:165–170 [View Article] [PubMed]
     [Google Scholar]
  37. Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 2008; 8:38 [View Article] [PubMed]
     [Google Scholar]
  38. Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E et al. Procalcitonin levels in Gram-positive, Gram-negative, and fungal bloodstream infections. Dis Markers 2015; 2015:701480 [View Article] [PubMed]
     [Google Scholar]
  39. Gao L, Liu X, Zhang D, Xu F, Chen Q et al. Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6. Exp Ther Med 2017; 13:3479–3483 [View Article] [PubMed]
     [Google Scholar]
  40. Wang C, Wang Q, Li R, Duan JY, Wang CB. Synovial fluid C-reactive protein as a diagnostic marker for periprosthetic joint infection: A systematic review and meta-analysis. Chin Med J (Engl) 2016; 129:1987–1993 [View Article] [PubMed]
     [Google Scholar]
  41. Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med 2014; 20:1334–1339 [View Article] [PubMed]
     [Google Scholar]
  42. Diepold M, Noellke P, Duffner U, Kontny U, Berner R. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis 2008; 8:28 [View Article] [PubMed]
     [Google Scholar]
  43. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443–451 [View Article] [PubMed]
     [Google Scholar]
  44. Oberhoffer M, Stonans I, Russwurm S et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134:49–55 [View Article] [PubMed]
     [Google Scholar]
  45. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102:5–14 [PubMed]
     [Google Scholar]
  46. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol 2004; 57:950–955 [View Article] [PubMed]
     [Google Scholar]
  47. Holub M, Klucková Z, Beneda B, Hobstová J, Huzicka I et al. Changes in lymphocyte subpopulations and CD3+/DR+ expression in sepsis. Clin Microbiol Infect 2000; 6:657–660 [View Article] [PubMed]
     [Google Scholar]
  48. Thomas-Rüddel DO, Poidinger B, Kott M, Weiss M, Reinhart K et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care 2018; 22:128 [View Article]
     [Google Scholar]
  49. Oussalah A, Ferrand J, Filhine-Tresarrieu P, Nejla A, Aimone G et al. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: An observational study of 35,343 consecutive patients. Medicine (Baltimore) 2015; 94:44–e1774
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001360
Loading
Serum biomarkers to differentiate Gram-negative, Gram-positive and fungal infection in febrile patients
J. Med. Microbiol. 70, 001360 (2021); https://doi.org/10.1099/jmm.0.001360
/content/journal/jmm/10.1099/jmm.0.001360
/content/journal/jmm/10.1099/jmm.0.001360
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error